Latest News & Features
Americas
The Supreme Court's first look at the skinny label dispute dug into key questions, from the role of the skinny label to who Hikma’s statements were really meant for, in one of the most important patent cases in years. 30 April 2026
Europe
Data from Questel indicates a radical restructuring of IP professionals’ duties, as adoption and demand rates continue to rise. 30 April 2026
Europe
The company’s rivals convinced an EPO appeals board to revoke a patent that had been used in litigation against them over Comirnaty. 30 April 2026
Careers
Patent litigator and attorney swaps the capital of Massachusetts for Los Angeles and San Francisco, bringing a broad patent practice across tech and life sciences. 30 April 2026
Americas
The wearable tech company has had to drop its lawsuit against US Customs and Border Protection, part of the wider, ongoing dispute with Apple over a blood oxygen feature in smart watches. 29 April 2026
Americas
Pharma group strikes an all-cash transaction, combining a portfolio expansion with a contingent payment linked to a dispute over a $5 billion drug 28 April 2026
Americas
BioNTech’s former rival—now part of its company—is seeking to assert its mRNA portfolio against Moderna in a new suit over modifications to the highly fought-over molecule. 28 April 2026
Americas
An event for IP, legal and compliance leaders to address the growing threat of trade secret misappropriation heads to San Jose. 28 April 2026
Europe
An opinion has put pressure on the CJEU to clarify a long-running grey area that could change the game for how drug makers secure supplementary protection certificates across Europe. 24 April 2026
Americas
The US pharma giant is spending up to $1 billion to build an end-to-end biosimilar platform and is counting on a decade of expiring biologic patents to make it pay off. 23 April 2026